Weak pharma progress in Q2 sparks issues
Regardless of a strong efficiency by homegrown pharma corporations within the June quarter, pushed by improved progress within the US ...
Regardless of a strong efficiency by homegrown pharma corporations within the June quarter, pushed by improved progress within the US ...
The expansion in Indian Pharma Market (IPM) softened a bit to five.3% yr on yr in December 2021, as in ...
The board of Ipca Labs has accepted the acquisition of 26.574% of the paid-up share capital of Lyka Labs Restricted ...
The Indian pharma market (IPM) continued to see healthy double-digit growth of 12.4% year-on-year in September. The growth rate however ...
[mc4wp_form id=”158″]
© 2021 Success News - Developed by Sawah Web.
© 2021 Success News - Developed by Sawah Web.